ImStem Biotechnology

Imstem Biotechnology, Inc. [pronounced as 'I am stem (cells)'] operates as a biotechnology firm with a focus on the development of cell therapeutic products derived from human pluripotent stem cells (hESC or iPSC) for the treatment of neural, heart, vascular, blood system diseases, and autoimmune diseases. Utilizing advanced stem cell technologies, they aim to offer various therapeutic and research products with an abundant supply and consistent quality in the near future.